ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Stryker to Feature Expanding Trauma Portfolio at the Orthopaedic Trauma Association Annual Meeting 2025

Stryker (NYSE: SYK), a global leader in medical technologies, will showcase new additions to its trauma offerings at the Orthopaedic Trauma Association (OTA) Annual Meeting, October 15–18, in Phoenix, Ariz. (booth #601). The company will highlight upcoming expansions to its nailing and plating platforms.

For more than 80 years, Stryker has collaborated with surgeons to help design their products and advance its trauma offerings through continuous innovation in nailing and plating. Building on that legacy, the Pangea platform and T2 Alpha system have been designed to simplify instrumentation, enhance stability and provide greater flexibility in managing complex fractures.

The new T2 Alpha Humeral nail is designed for simplicity and engineered to achieve optimal outcomes. Once available, it will provide surgeons with an implant that may help improve patient lives, streamline humeral fixation and support efficient surgical workflows.

Also on the horizon is a novel femur reconstruction fracture system that brings together two of Stryker’s most widely adopted platforms, T2 Alpha and the Pangea platform. With this innovation, Stryker's trauma portfolio offers differentiating technology – a system designed for complex femur fractures requiring a dual construct – through streamlined instrumentation and differentiated implants. By combining the strength of T2 Alpha with the versatility of the Pangea platform, this solution helps surgeons tackle even the most challenging and complex native and periprosthetic femur fractures.

“Expanding our trauma portfolio reflects our ongoing commitment to support surgeons and care teams with technologies built to be both reliable and adaptable,” said Eric Tamweber, vice president and general manager of Stryker’s Trauma business. “Our latest solutions are engineered to help tackle challenging cases while promoting efficiency and safety in the OR. We are listening to our customers and evolving with them, validating the tools they need to move trauma care forward. Together, we are a full force in advancing trauma care.”

Attendees can visit Stryker’s booth #601 for hands-on demonstrations and conversations with experts.

About Stryker

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.

Copyright © 2025 Stryker

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  221.09
+0.00 (0.00%)
AAPL  259.58
+0.00 (0.00%)
AMD  234.99
+0.00 (0.00%)
BAC  51.76
+0.00 (0.00%)
GOOG  253.73
+0.00 (0.00%)
META  734.00
+0.00 (0.00%)
MSFT  520.56
+0.00 (0.00%)
NVDA  182.16
+0.00 (0.00%)
ORCL  280.07
+0.00 (0.00%)
TSLA  448.98
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.